Dr. Lawrence J. Gogenola, MD
Dermatology (Dermatology Physician)
1551 116th Ave Ne
Bellevue, WA 98004
Who else practices at this address →
King County includes primary care (5% of residents) and dental (4% of residents) and mental health (4% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- University of Washington School of Medicine (1982)
- Years since graduation
- 44
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 258
Licensed in Washington since 1987, according to the Washington State Department of Health. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1982Medical school: University of Washington School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Dermatology Physician primary
WA license MD00024909 (first issued 1987; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Medicare patients and services
- Medicare patients, 2024
- 258
- Services billed
- 921
- Patients’ average age
- 78
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 213 | 153 |
| Destruction of precancer skin growth, 2-14 growths | 202 | 70 |
| Established patient office or other outpatient visit, 10-19 minutes | 168 | 118 |
| Destruction of precancer skin growth, 1 growth | 131 | 103 |
| Biopsy of related skin growth, first growth | 67 | 57 |
| Destruction of skin growth, 1-14 growths | 38 | 35 |
| New patient office or other outpatient visit, 15-29 minutes | 24 | 24 |
| New patient office or other outpatient visit, 30-44 minutes | 23 | 23 |
| Biopsy of related skin growth, each additional growth | 19 | 12 |
| Punch biopsy, first skin growth | 15 | 14 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 16 companies reported 107 payments worth $2,096 in total to this clinician.
| AbbVie Inc. | $389 |
|---|---|
| Genzyme Corporation | $321 |
| Novartis Pharmaceuticals Corporation | $213 |
| Pfizer Inc. | $209 |
| UCB, Inc. | $152 |
| Galderma Laboratories, L.P. | $145 |
| Amgen Inc. | $144 |
| Sun Pharmaceutical Industries Inc. | $116 |
| Food and Beverage | $2,096 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.